Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 18 - Sayı: 4

Analysis of geographical variations in the epidemiology and management of non-valvular atrial fibrillation: results from the RAMSES registry

Pages
273–280
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patients were divided into seven groups based on the geographical region of residence.Results: In terms of the geographical distribution of the overall Turkish population, the highest number of patients were enrolled from Marmara (1677, 26.7%).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to determine the differences in terms of demographic characteristics and preferred stroke prevention strategies for patients with non-valvular atrial fibrillation living in seven geographical regions of Turkey.Methods: In total, 6273 patients were enrolled to this prospective, observational RAMSES study.
📊
Key Findings & Data:The patients were divided into seven groups based on the geographical region of residence.Results: In terms of the geographical distribution of the overall Turkish population, the highest number of patients were enrolled from Marmara (1677, 26.7%).
💡
Conclusion & Impact:OACs are still under- or inappropriately utilized, particularly in the eastern provinces of Turkey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to determine the differences in terms of demographic characteristics and preferred stroke prevention strategies for patients with non-valvular atrial fibrillation living in seven geographical regions of Turkey.Methods: In total, 6273 patients were enrolled to this prospective, observational RAMSES study. The patients were divided into seven groups based on the geographical region of residence.Results: In terms of the geographical distribution of the overall Turkish population, the highest number of patients were enrolled from Marmara (1677, 26.7%). All demographic characteristics were significantly different among regions. Preferred oral anticoagulants (OACs) also differed between geographical regions; non-vitamin K OACs were preceded by warfarin in East Anatolia, Aegean, Southeast Anatolia, and Black Sea. Nearly one-third of the patients (28%) did not receive any OAC therapy. However, the number of patients not receiving any OAC therapy was higher in Southeast Anatolia (51.1%) and East Anatolia (46.8%) compared with other geographical regions of Turkey. Inappropriate use of OACs was also more common in East and Southeast Anatolia.Conclusion: This study was the first to show that the demographic differences among the geographical regions may result in different preferences of stroke prevention strategies in Turkey. OACs are still under- or inappropriately utilized, particularly in the eastern provinces of Turkey.

🔖

Cite This Article

DOĞAN, V., BAŞARAN, Ö., BİTEKER, M., ÖZPAMUK, F. K., TEKKEŞİN, A. İ., ÇAKILLI, Y., TÜRKKAN, C., HAMİDİ, M., DEMİR, V., GÜRSOY, M. O., TEK, M. Ö., AKSAN, G., SEYİS, A. S., BALLI, M., ALICI, M. H., BOZYEL, S., KIRMA, C. (2017). Analysis of geographical variations in the epidemiology and management of non-valvular atrial fibrillation: results from the RAMSES registry. The Anatolian Journal of Cardiology, Cilt: 18 - Sayı: 4, 273–280. https://ajindex.com/articles/366712

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2016;37:2893-962
  2. Durrant J, Lip GY, Lane DA. Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives. Expert Rev Cardiovasc Ther 2013;11:77-90
  3. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72
  4. Başaran Ö, Beton O, Doğan V, Tekinalp M, Aykan AÇ, Kalaycıoğlu E, et al. ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study), Anatol J Cardiol 2016;16:734-41
  5. Başaran Ö, Doğan V, Beton O, Tekinalp M, Aykan AC, Kalaycıoğlu E, et al. Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study. Medicine (Baltimore) 2016;95:e4672
  6. Agarwal S, Bennett D, Smith DJ. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Am J Cardiovasc Drugs 2010;10:37-48
  7. Lewis WR, Fonarow GC, LaBresh KA, Cannon CP, Pan W, Super DM, et al. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol 2009;103:227-31
  8. Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 2014;11:276-89
  9. Özaslan M, Dinçer B, Özgür H. Regional Disparities and Territorial Indicators in Turkey: Socio-Economic Development Index (SEDI) Enlargement, Southern Europe, and the Mediterranean, Volos, Greece: The department of planning and regional development, University of Thessaly and the Greek section of ERSA, Paper presented at: 46th Congress of the European Regional Science Association (ERSA); Volos, Greece 2006
  10. Çelebioğlu F, Dall'erba S. Spatial disparities across the regions of Turkey: an exploratory spatial data analysis. Ann Reg Sci 2010; 45:379-400
  11. Başkent University/Ministry of Health/Refik Saydam Hygiene Center Preside